Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Hedgehog signaling in glioblastoma
$537,026David R Raleigh · University Of California, San Francisco · R01 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$536,912Philip D Greenberg · University Of Washington · R01 · FY2015 · CA
Delineating Functional Immunity via Image-Guided PET
$536,875Nerissa Therese Viola · Wayne State University · R37 · FY2022 · CA
Inflammation as determinant of clonal selection in MPN progression
$536,869Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2019 · HL
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$536,866Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2024 · CA
EZH2 in cancer biology and novel inhibitors
$536,827Jun Qi · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Surgical Oncology Research Training Grant
$536,822Babak J Mehrara · Sloan-Kettering Inst Can Research · T32 · FY2025 · CA
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$536,764Naoto T Ueno · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
UCLA Tumor Immunology Institutional Traning Grant
$536,711Michael A Teitell · University Of California Los Angeles · T32 · FY2022 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2016 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2015 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2017 · CA
Core 3: Mouse Models Core (MM Core)
$536,694Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2025 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$536,674George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Dissecting NF-kB pathway in HPV-associated head and neck cancer
$536,605Wendell G Yarbrough · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DE
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$536,602Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
$536,535Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$536,528Bryan Quilty Spring · Northeastern University · U01 · FY2025 · CA
c-Myc Targets in the Pathogenesis of Human Cancers
$536,384Chi V. Dang · Wistar Institute · R01 · FY2020 · CA
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
$536,289Erika L Pearce · Johns Hopkins University · R01 · FY2021 · AI
Artemin overexpression in oral cancer pain and carcinogenesis
$536,258Donna G Albertson · New York University · R01 · FY2022 · CA
Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system
$536,240Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2023 · CA
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
$536,086Erin Giles · University Of Michigan At Ann Arbor · R01 · FY2024 · CA